SEEK Limited (ASX:SEK)

Sage Therapeutics Income Statement

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Revenue	1,062	1,084	1,158	1,117	760.3	650.6
Revenue Growth (YoY)	-5.45%	-6.37%	3.71%	46.85%	16.86%	-58.22%
Cost of Revenue	425	413.8	412.2	386.4	300.7	239
Gross Profit	637.3	670.3	745.7	730.1	459.6	411.6
Selling, General & Admin	149.6	162.2	173.8	184.2	91	133
Research & Development	83.4	84.8	68.6	71.6	55	46.1
Other Operating Expenses	-4.5	-4.5	-4.1	-2.7	-	-
Operating Expenses	374.6	371.1	337.3	342.8	229.9	255.8
Operating Income	262.7	299.2	408.4	387.3	229.7	155.8
Interest Expense	-75.7	-74.9	-70.1	-46.3	-47.4	-56.6
Interest & Investment Income	6.4	6.4	4.7	2.9	1.3	5.2
Earnings From Equity Investments	49.2	-146.4	-31.4	5.3	4.1	-8.8
Other Non Operating Income (Expenses)	-3.2	-2.7	-4.7	-7.3	-2.5	4.9
EBT Excluding Unusual Items	239.4	81.6	306.9	341.9	185.2	100.5
Impairment of Goodwill	-	-	-	-	-12.7	-129
Gain (Loss) on Sale of Investments	-119.8	-119.8	-1.9	-	-	-
Asset Writedown	-	-	-	-	-34.2	-74.1
Other Unusual Items	-	-	-	-	-	0.2
Pretax Income	119.6	-38.2	305	341.9	138.3	-102.4
Income Tax Expense	69.6	21.7	74.7	101.1	33.8	20.9
Earnings From Continuing Operations	50	-59.9	230.3	240.8	104.5	-123.3
Earnings From Discontinued Operations	-37.2	-41	815.3	-72	647.3	8.1
Net Income to Company	12.8	-100.9	1,046	168.8	751.8	-115.2
Minority Interest in Earnings	-	-	-	-	0.4	2.1
Net Income	12.8	-100.9	1,046	168.8	752.2	-113.1
Net Income to Common	12.8	-100.9	1,046	168.8	752.2	-113.1
Net Income Growth	-97.76%	-	519.43%	-77.56%	-	-
Shares Outstanding (Basic)	357	356	355	354	353	352
Shares Outstanding (Diluted)	357	356	357	356	356	352
Shares Change (YoY)	-0.16%	-0.14%	0.23%	0.09%	1.01%	-0.43%
EPS (Basic)	0.04	-0.28	2.95	0.48	2.13	-0.32
EPS (Diluted)	0.04	-0.28	2.93	0.47	2.12	-0.32
EPS Growth	-97.77%	-	518.77%	-77.61%	-	-
Free Cash Flow	329.5	316.2	313.5	376	292.3	292.9
Free Cash Flow Per Share	0.92	0.89	0.88	1.06	0.82	0.83
Dividend Per Share	0.400	0.350	0.470	0.440	0.200	0.130
Dividend Growth	-10.11%	-25.53%	6.82%	120.00%	53.85%	-71.74%
Gross Margin	59.99%	61.83%	64.40%	65.39%	60.45%	63.27%
Operating Margin	24.73%	27.60%	35.27%	34.69%	30.21%	23.95%
Profit Margin	1.21%	-9.31%	90.30%	15.12%	98.94%	-17.38%
Free Cash Flow Margin	31.02%	29.17%	27.07%	33.68%	38.45%	45.02%
EBITDA	298.4	317.4	424.5	400.2	265.2	223.4
EBITDA Margin	28.09%	29.28%	36.66%	35.84%	34.88%	34.34%
D&A For EBITDA	35.7	18.2	16.1	12.9	35.5	67.6
EBIT	262.7	299.2	408.4	387.3	229.7	155.8
EBIT Margin	24.73%	27.60%	35.27%	34.69%	30.21%	23.95%
Effective Tax Rate	58.19%	-	24.49%	29.57%	24.44%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.